New quinoxaline compounds as DPP-4 inhibitors and hypoglycemics: design, synthesis, computational and bio-distribution studies.

Syam, Yasmin M; Anwar, Manal M; Abd El-Karim, Somaia S; Elseginy, Samia A; Essa, Basma M; Sakr, Tamer M

Syam, Yasmin M; Anwar, Manal M; Abd El-Karim, Somaia S; Elseginy, Samia A; Essa, Basma M; Sakr, Tamer M.

Afiliação

Syam YM; Department of Therapeutic Chemistry, National Research Center Dokki Cairo 12622 Egypt manal.hasan52@live.com.
Anwar MM; Department of Therapeutic Chemistry, National Research Center Dokki Cairo 12622 Egypt manal.hasan52@live.com.
Abd El-Karim SS; Department of Therapeutic Chemistry, National Research Center Dokki Cairo 12622 Egypt manal.hasan52@live.com.
Elseginy SA; Green Chemistry Department, National Research Center Dokki Cairo 12622 Egypt.
Essa BM; Radioactive Isotopes and Generator Department, Hot Laboratories Centre, Egyptian Atomic Energy Authority (EAEA) P.O. Box 13759 Cairo Egypt.
Sakr TM; Radioactive Isotopes and Generator Department, Hot Laboratories Centre, Egyptian Atomic Energy Authority (EAEA) P.O. Box 13759 Cairo Egypt.

RSC Adv ; 11(58): 36989-37010, 2021 Nov 10.

Article em En | MEDLINE | ID: mdl-35494381

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: RSC Adv Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google